Black Diamond Therapeutics remains undervalued despite recent share price gains, with a promising EGFR inhibitor pipeline ...
Zipalertinib's NDA submission is based on promising efficacy data from the REZILIENT1 trial, showing a 35.2% ORR and ...
Circ-EGFR was identified as a novel predictive biomarker for cetuximab efficacy in KRAS wild-type metastatic colorectal ...
Targeted cancer therapies like CDK4/6, EGFR, VEGFR, and BRAF inhibitors may increase long-term kidney dysfunction risk. Learn ...
Andamertinib showed promising efficacy in NSCLC patients with EGFR exon 20 mutations, achieving a 42.7% ORR in the 240-mg cohort.
Over the past decade, several tumor-based predictors of cetuximab efficacy have been identified, yet most function as ...
This article was reviewed by Felix Gussone, MD. What Is Biomarker Testing? How It Works and Why It Matters for Men’s Health ...
Expert discusses how the prevalence of chronic kidney disease (CKD), as reflected by decreased estimated glomerular ...
The FDA has granted fast track designation to the EGFR/HER3 bispecific antibody-drug conjugate (ADC) AVZO-1418 for treatment ...
MedPage Today on MSN
Two Kidney Function Measures Are Not Always Aligned With Each Other
HOUSTON -- Two commonly used kidney function tests had a large degree of disagreement and were linked with serious health outcomes in patients with chronic kidney disease (CKD), according to a ...
One-year program includes diet, exercise, stress relief, and physician consultations. Glycemic control and other markers ...
Breast cancer is a highly heterogeneous malignancy among women worldwide. Traditional prognostic models relying solely on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback